CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection

Journal of Experimental Medicine

Volumn 195, Issue 7, 2002, Pages 869-879

  Motsinger, Alison ^a   Haas, David W ^a,b   Stanic, Aleksandar K ^a   Van Kaer, Luc ^a   Joyce, Sebastian ^a   Unutmaz, Derya ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD1d tetramer; Chemokine receptors; Cytokines; HIV; NKT cell

Indexed keywords

CD1 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GALACTOSYLCERAMIDE; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MALE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, CD14; CELL CULTURE TECHNIQUES; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4;

EID: 0036534552     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011712     Document Type: Article

References (70)

1. Mouse CD1-specific NK1 T cells: Development, specificity, and function
2. Recognition and function of Vα14 NKT cells
3. CD1d and natural T cells: How their properties jump-start the immune system
4. - α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain
5. - T cells
6. - and heterogeneous with respect to TCR-β expression
7. - T cells
8. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes
9. + thymocytes selected by MHC class I molecules
10. Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR
11. + NKT lymphocytes are activated memory cells
12. + NKT cells in germ-free mice
13. Human natural killer T cells acquire a memory-activated phenotype before birth
14. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides
15. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
16. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells
17. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains
18. TCR Vα 24 and Vβ 11 co-expression defines a human NK1 T cell analog containing a unique Th0 subpopulation
19. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1
20. Cutting edge: Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
21. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi
22. + v(α)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major
23. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus
24. NK cells and NKT cells in innate defense against viral infections
25. CD1-specific T cells in microbial immunity
26. Co-receptors for HIV-1 entry
27. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
28. Chemokines, cytokines and HIV: A complex network of interactions that influence HIV pathogenesis
29. + T cell decline
30. + T cells are infected in human immunodeficiency virus type 1-infected individuals
31. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1
32. Virus and target cell evolution in human immunodeficiency virus type 1 infection
33. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
34. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
35. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: Evidence supporting a role for Nef at the virion envelope
36. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage
37. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression
38. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: Allergics vs. non-allergics
39. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution
40. Cell surface down-modulation of CD4 after infection by HIV-1
41. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4
42. Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy
43. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
44. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling
45. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 α
46. The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse
47. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
48. CCR7 expression and memory T cell diversity in humans
49. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
50. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential
51. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
52. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
53. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
54. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission
55. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men
56. Selective reduction of T cells bearing invariant Vα24Jα Q antigen receptor in patients with systemic sclerosis
57. + NK T cells associated with disease development in autoimmune-prone mice
58. +-like thymocytes in the NOD mouse
59. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage
60. + double-negative regulatory natural killer T cells in autoimmune diseases
61. + TCR α/β intermediate liver lymphocytes are down-regulated by Listeria monocytogenes
62. Selective loss of natural Miler T cells by apoptosis following infection with lymphocytic choriomeningitis virus
63. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: A major role for bone marrow in NKT cell homeostasis
64. NKT cells: Facts, functions and fallacies
65. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
66. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
67. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
68. + T cells and rapid elimination of effector cells by apoptosis
69. + T cells upon NK T or T cell activation
70. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells